AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 282: R870-R880, 2002; doi:10.1152/ajpregu.00374.2001
0363-6119/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Régnauld, K. L.
Right arrow Articles by Emami, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Régnauld, K. L.
Right arrow Articles by Emami, S.
Vol. 282, Issue 3, R870-R880, March 2002

Activation of adenylyl cyclases, regulation of insulin status, and cell survival by Galpha olf in pancreatic beta -cells

Karine L. Régnauld1, Emmanuelle Leteurtre2, Silvio J. Gutkind3, Christian P. Gespach1, and Shahin Emami1

1 Institut National de la Santé et de la Recherche Médicale U482, Signal Transduction and Cellular Function in Diabetes and Digestive Cancers, Saint-Antoine Hospital, 75571 Paris Cedex 12; 2 Institut National de la Santé et de la Recherche Médicale U377, Place de Verdun, 59045 Lille Cedex, France; and 3 National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892-6401


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Because we recently identified the Galpha olf subunit in rat pancreatic beta -cells, we investigated the downstream effectors and the biological functions of this G protein in HEK-293T cells and the insulin-secreting mouse beta TC-3 cell line. With the use of transient transfection of HEK-293T cells with constitutively activated Galpha olf (Galpha olfQ214L, i.e., AGalpha olf), together with expression vectors encoding the adenylyl cyclase (AC) isoforms (AC-I to -VIII and soluble AC), compared with cotransfections using AGalpha s (Galpha sR201C), we observed that AGalpha olf preferentially activates AC-I and -VIII, which are also expressed in beta -cells. Stable overexpression of wild-type or AGalpha olf in beta TC-3 cells resulted in partial attenuation of insulin secretion and biosynthesis, suggesting that chronic activation of the Galpha olf-signaling pathway is associated with beta -cell desensitization. In agreement, transfected beta TC-3 cells present a decreased insulin content with respect to parental cells, whereas the proinsulin convertases PC-1 and PC-2 were unaffected. Furthermore, beta TC-3-AGalpha olf cells are resistant to serum starvation-induced apoptosis. Our findings suggest that Galpha olf is involved in insulin status, cell survival, and regeneration of the insulin-secreting beta -cells during development and diabetes.

Galpha olf subunit; apoptosis; diabetes; regeneration


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

DIABETES REMAINS A MAJOR PUBLIC health concern, with a high frequency and many associated outgrowing genetic anomalies. It is characterized by the loss of postprandial insulin secretion by beta -cells in response to glucose and nutrients. Desensitization of pancreatic beta -cells leads to progressive reduction of the insulin beta -cell population and chronic hyperglycemia (19). Most of the mechanisms behind this alteration in signal-secretion coupling and insulin status are unclear. Hyperglycemia impairs beta -cell function in type 2 diabetes through multiple dysfunctions along the cAMP pathway, insulin secretion, and biosynthesis (35). Alterations in G protein-coupled receptor signaling constitute the potential targets for pancreatic beta -cell desensitization in diabetes (13, 38). In beta -cells, the glucose-dependent insulinotropic polypeptide (GIP) and its structurally related peptides, truncated glucagon-like polypeptide 1 (tGLP-1) and pituitary adenylyl cyclase (AC)-activating polypeptide, are critical activators of the cAMP pathway and potentiate glucose-induced insulin release, insulin gene transcription, and beta -cell growth (13).

The membrane-bound ACs are critical effectors of the Galpha s family of G-protein subunits acting through cAMP production and protein kinase A (PKA) activation. Recent studies demonstrated that the cAMP pathway is also connected with several other downstream signaling cascades, including cyclic nucleotide-gated ion channels and Epacs (exchange protein directly activated by cAMP), which are guanine-nucleotide-exchange factors (cAMP-dependent GEFs) for the small G protein Rap1 (12, 29).

Galpha olf, a member of the Galpha s family originally discovered in the olfactory neuroepithelium and striatum, was subsequently identified in peripheral tissues, including testis, spleen, lung, and heart (16, 23, 37, 46). Recently, we identified Galpha olf in pancreatic beta -cells by in situ hybridization, immunocytochemistry, and electron microscopy (2). In Langerhans islets, Galpha olf is located inside the insulin-secretory granules and beta -cell plasma membrane, suggesting that it is involved in granule migration, processing, and exocytosis. Galpha olf has an 88% amino acid homology with Galpha s, as it comprises three conserved functional domains involved in guanosine triphosphate (GTP)-binding affinity, GTPase activity, receptor-dependent GTP binding, and GTP-induced conformational change (22). To date, the molecular partners of the Galpha olf-signaling cascade in beta -cells, including upstream activation by serpentine receptors and Galpha olf downstream transduction elements, are still unknown. Due to the sequence divergences between Galpha olf and Galpha s (23, 27), we postulated that these two G-protein subunits receive distinct upstream extracellular signals and exert a differential functional activation on the AC isoforms downstream.

Nine AC isoenzymes, AC-I to -IX, and two splice variants of AC-VIII have been identified in mammals. Most of these isoenzymes are present in Langerhans islet beta -cells and are overexpressed in diabetic animal models (21, 28, 40). Recently, a new mammalian soluble AC (sAC) isoenzyme insensitive to forskolin (FK) was described in testis (8).

The present study was therefore conducted to identify the AC isoforms preferentially activated by Galpha olf in transient transfection assays and the cellular functions controlled by this G protein in mouse insulin-secreting beta TC-3 cells. For this purpose, we first cotransfected the human embryonic kidney cell line HEK-293T using a constitutively active GTPase-deficient form of Galpha olf (Galpha olfQ214L) and of Galpha s (Galpha sR201C), respectively, designated below as AGalpha olf and AGalpha s, together with expression vectors encoding each of the individual AC isotypes (AC-I to -VIII) or sAC. Second, we established the beta TC-3 cell lines stably transfected with wild-type (wt)Galpha olf or AGalpha olf to explore the potential role of Galpha olf on the insulin status and cell survival, which constitute two major impacts on the functional beta -cell abnormalities in type 2 diabetes. Thus we measured insulin accumulation, secretion, and the expression of the prohormone convertases (PC) 1 and 2 in beta TC-3-wtGalpha olf and -AGalpha olf-transfected cells (39). We showed 1) that the G protein Galpha olf preferentially activates AC-I and AC-VIII in transiently transfected HEK-293T cells, 2) that overexpression of wt- or AGalpha olf weakened cAMP and insulin responses to the G protein-coupled receptors tGLP-1 in beta TC-3 cells, and 3) that AGalpha olf protected beta -cells from the apoptosis induced by serum withdrawal.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell culture and human insulinomas. Human embryonic kidney HEK-293T epithelial cells were maintained in DMEM containing 25 mM glucose (GIBCO-BRL, Life Technologies) supplemented with 10% fetal bovine serum (FBS; Boehringer Mannheim), L-glutamine, and antibiotics. The human collecting duct (HCD) cell line immortalized by SV40 virus, a generous gift from Dr. P. Ronco (Institut National de la Santé et de la Recherche Médicale U489), was cultured in DMEM consisting of Ham's F-12 medium (vol:vol) containing 2% FBS, 5 µg/ml transferrin, 50 nM sodium selenite, 2 mM L-glutamine, 0.5 nM dexamethasone, 5 µg/ml insulin, and 20 mM HEPES (36). Pancreatic beta TC-3 cells derived from transgenic mice expressing SV40-T antigen in Langerhans beta -cells were a generous gift from Dr. Shimon Efrat (Albert Einstein College of Medicine, Bronx, NY). beta TC-3 cells were grown in DMEM containing 5 mM glucose supplemented with 12.5% horse serum, 2.5% FBS (Biowest, Paris, France), L-glutamine, and antibiotics (10). Human insulinomas were well-differentiated endocrine tumors by microscopic examination and according to the detection of insulin by immunohistochemistry.

Plasmid DNA preparations. Mammalian expression vector encoding wtGalpha olf was constructed by a 2.7-kbp NotI-SalI fragment excision from pBluescript SK+, corresponding to whole rat Galpha olf cDNA, and inserted in a frame into the corresponding sites of the pCI-neo vector (Promega). To generate the hemagglutinin (HA)-tagged and GTPase-deficient mutant of Galpha olf encoding the constitutively activated form of this G protein (HA-AGalpha olf), a first generation of DNA fragments of 3'-EcoRI/Bsu36I and Bsu36I/BglII-5' was amplified by PCR. With the use of these fragments as a template, a second generation of 3'-EcoRI/BglII-5' fragments was amplified, thus introducing a point mutation in Galpha olf by replacing glutamine 214 with leucine (Galpha olfQ214L), which is involved in constitutive GTP binding to Galpha olf and in the inhibition of intrinsic GTPase activity. The primer sequences are available on request. The PCR-amplified 1.15-kbp DNA fragment was inserted in a frame into the corresponding sites of pCEFL, a modified pcDNA3 expression vector containing the elongation factor 1 promoter that drives the expression of an inframe NH2-terminal tag of nine amino acids of the HA epitope. All constructs were verified by DNA sequencing and expression in HEK-293T cells. Sequences were also identified by BLAST analysis of the GenBank database. The cDNA encoding the constitutively activated form of the G-protein subunit Galpha sR201C (HA-AGalpha s) was cloned in the expression vector pCEFL. sAC (8) was a generous gift from Dr. L. Levin (Weill Medical College, Cornell University, NY). The membrane-bound AC isoforms AC-I, -II, and -V in pXMD1 (14, 24, 43) were a generous gift from Dr. T. Pfeuffer (Zentrum für Molekulare Biologie, Heidelberg, Germany); AC-III, -IV, -VI, and -VII in pXMD1 (3, 4, 18, 25, 44) were gifts from Drs. R. R. Reed, A. Gilman (University of Texas, Austin, TX), and P. Watson (Weis Center, Geisinger Clinic, Danville, PA); and AC-VI and -VIII in pCMV-neo (9, 25) were gifts from Dr. Krupinski (Bristol-Myers Squibb, Princeton, NJ). The pCMV-beta -gal vector expressing beta -galactosidase was purchased from Clontech Laboratories (Palo Alto, CA).

Transient cotransfection assays. HEK-293T cells were plated at the density of 75 × 103 cells per 6-well petri dish and cultured for 24 h. Cells were transiently transfected using LipofectAMINE Plus reagent, according to the manufacturer's protocol (GIBCO-BRL). Briefly, HEK-293T cells were transfected with the AGalpha olf (1 µg) or AGalpha s (0.2 µg) expression vectors, either alone or combined with one of the AC expression vectors (0.2 µg), together with 0.1 µg pcDNA3-beta -gal. To transfect constant amounts of DNA, samples were supplemented with the control vector pCEFL. Transfection efficiency of 40-50% was optimized and determined by both X-GAL staining and beta -galactosidase activity using the Luminescence Galacto-Star kit (Tropix, Bedford, MA). After incubation at 37°C for 6 h in a humidified atmosphere of 5% CO2 and 95% air, the remaining DNA-liposome complexes were removed. HEK-293T cells were then cultured for 24, 48, or 72 h in the standard medium and challenged for the cAMP assay described below.

Stable transfection of beta TC-3 cells. Approximately 2 × 106 beta TC-3 cells in 100-mm-diameter petri dishes were stably transfected by the LipofectAMINE Plus reagent with the pCI-neo-wtGalpha olf or pCEFL-AGalpha olf expression plasmid. Transfection efficiencies were 10-12%, as determined by beta -galactosidase staining. After 3 days, transfected cells were selected for 3 wk of culture in 400 µg/ml G-418 (Geneticin, GIBCO-BRL, Life Technologies). Resistant colonies were either ring-cloned as individual colonies of beta TC-3-wtGalpha olf cells or pooled as beta TC-3 cells expressing constitutively activated AGalpha olf (beta TC-3-AGalpha olf pools). Cells were subjected to analysis of ectopic overexpression of the Galpha olf transgenes by immunoblot analysis or RT-PCR and further tested for cAMP generation, insulin status, and cell survival.

Western blot analysis. For immunoblotting, cultured cells were homogenized for 30 min at 4°C in lysis buffer containing 20 mM HEPES buffer at pH 7.5, 10 mM EGTA at pH 8.0, 2.5 mM MgCl2, 40 mM beta -glycerophosphate, 2 mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, and 2% leupeptin and aprotinin as phosphatase and protease inhibitors. Proteins were resolved by 12.5% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, Little Chalfont, UK). The membranes were blocked with 10% defatted milk and probed for 4 h at room temperature with one of the following antibodies: the monoclonal antibody (mAb) 3F10 (1:500) that recognizes the HA peptide sequence YPYDVPDYA of the human hemaglutinin protein (Hoffmann-La Roche, Basel, Switzerland); the Galpha olf polyclonal antibody (pAb) K19 (1:500) (Santa Cruz Biotechnology, Santa Cruz, CA); the mAb AC-15 specific for beta -actin (1:4,000) (Sigma-Aldrich, Saint-Quentin Fallavier, France); and the pAbs 2B6 and 4BF (39) directed against the protein convertases PC-1 and PC-2 (1:1,000), a generous gift from Dr. P. Kitabgi (Centre National de la Recherche Scientifique, Valbonne, France). After being blocked, membranes were washed in PBS containing 0.1% Tween-20 and probed for 90 min with a secondary antibody (1:2,000) consisting of horseradish peroxidase (HP)-linked goat anti-mouse IgGs pAb (Santa Cruz Biotechnologies) or HP-linked donkey anti-rabbit IgG (Amersham). Immunoblots were revealed by enhanced chemiluminescence (ECL) Plus Western detection from Amersham Pharmacia Biotech.

RT-PCR. Total RNA was extracted by the TRIzol reagent (GIBCO-BRL, Life Technologies) from human tissues (insulinomas and their adjacent pancreatic tissues and testis) and cultured cell lines (HEK-293T, HCD, and beta TC-3 cells). RT-PCR was performed using the Superscript detection kit (GIBCO-BRL, Life Technologies), according to the manufacturer's protocol. The experiment comprised one cycle of 30 min at 55°C and one of 2 min at 94°C followed by 40 cycles of 30 s at 94°C, 30 s at 55°C, and 1 min at 72°C, with a final extension time of 10 min at 72°C. For amplification of the human and rat Galpha olf cDNAs, human insulin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs, we used the following sense and antisense oligonucleotides (Genset, Ivry, France): hGalpha olf, 5'-CAGCGTCAGCTTGGTTGACTA-3' and 5'-GTAATGTTTGCCGTCACCGGT-3'; rGalpha olf, 5'-ATGGGGTGTTTGGGCAACAGC-3' and 5'-ACTCACGCTGTCAATCCTTTC-3'; human insulin, 5'-TGCATCAGAAGAGGCCATCAAGCA-3' and 5'-GAGAGATGGAATAAAGCCCTTGAAC-3'; and the human and mouse GAPDH, 5'-ATCACCATCTTCCAGGAGCG-3' and 5'-CAAGAAGGTGGTGAAGCAGG-3'. The primers amplified the 526-bp fragment specific for the hGalpha olf transcript, the 519-bp rGalpha olf amplicon, and the 444- and 574-bp products corresponding to the insulin and GAPDH messengers, respectively. PCR products were then separated by electrophoresis in 1.5% agarose gel and detected under ultraviolet light. DNA sequencing (Genset) confirmed the specificity of the amplified products for human and rat Galpha olf.

cAMP assay. For measurement of cAMP generation in transiently transfected HEK-293T cells (24-72 h posttransfection), the culture medium was replaced by 1 ml DMEM containing 1% BSA, 20 mM HEPES, and 1 mM isobutylmethylxantine (IBMX), a phosphodiesterase inhibitor. After 10 min of preincubation at 37°C, cells were further incubated for 1 h either alone or in the presence of the AC activators, 10 µM FK (Sigma-Aldrich), or 5 mM MnCl2. Parental beta TC-3 cells stably transfected with wtGalpha olf and AGalpha olf (3 × 105 cells) were cultured for 4 days before cAMP assay. The assay was performed in Krebs-Ringer bicarbonate (KRB) buffer containing 129 mM NaCl, 5 mM NaHCO3, 4.8 mM KCl, 1.2 mM KH2PO4, 2.5 mM CaCl2, 1.2 mM MgSO4, 5 mM glucose, 0.1% BSA, and 10 mM HEPES (pH 7.4). beta -Cells were incubated in 3 ml KRB buffer for 1 h at 37°C, alone or in the presence of 0.5 mM IBMX, or 0.1 µM tGLP-1 or both (Sigma-Aldrich). Aliquots of the supernatant (200 µl) were then removed for the insulin assay. HEK-293T or beta TC-3 cells were lysed by the addition of ice-cold perchloric acid (1.1 M final concentration). cAMP content was measured by RIA (Amersham Pharmacia Biotechnology) using the succinylated 125I-cAMP RIA competition method (7). Data were expressed as picomoles of cAMP produced per milligram protein for HEK-293T cells or per 106 cells for beta TC-3 cells.

The functionality of each AC isoform introduced by transient transfection in HEK-293T cells was calculated using the following formula where the FK-induced stimulation of each ectopic AC over FK-induced elevation of endogenous AC was
FK (ectopic AC) − ectopic AC

/FK (endogenous AC <IT>i.e.</IT> pCEFL) − pCEFL
in which the cAMP generated by a given AC isoform (0.2 µg plasmid cDNA) was measured in HEK-293T cells and expressed as the fold elevation of FK-induced activation of ectopic AC, minus its corresponding basal activity, and divided by the corresponding values obtained from endogenous AC in AGalpha olf submitted to the mock transfection (pCEFL empty vector).

Differential activation of each ectopic AC isoform by AGalpha s and AGalpha olf vectors was calculated using the following formula
AG&agr;olf (ectopic AC) − AG&agr;olf/AG&agr;s (ectopic AC) − AG&agr;s
in which the cAMP levels generated by each ectopic AC isoform in the presence of AGalpha olf, minus the cAMP induced by endogenous AC in response to AGalpha olf, were divided by the same values as those obtained in HEK-293T cells transfected with AGalpha s.

Insulin assay. After incubation of beta TC-3 cells for 1 h at 37°C, insulin secretion was measured in the 200-µl KRB buffer aliquot used for cAMP determination. Insulin secretion was also measured in parental beta TC-3 cells and their stably transfected counterparts beta TC-3-wtGalpha olf and beta TC-3-AGalpha olf cells after 24 h of culture (10). Supernatants were then saved for insulin determination, and cells were lysed in ethanol acid for measurement of their total insulin content. Media and cell extracts were centrifuged, and the supernatants were stored at -20°C. Samples were then assayed by RIA using a commercially available radioimmunoassay kit (Insulin-CT-RIA, CIS Bio International, Gif-sur-Yvette, France). Data were expressed as milliunits of insulin per 106 cells.

Apoptosis assay. beta TC-3 parental cells and stably transfected beta TC-3-AGalpha olf cells were plated at the density of 75 × 104 cells in petri dishes (60-mm diameter) in the presence or absence of serum. For fluorescence-activated cell sorter (FACS) analysis, floating cells were combined with trypsinized adherent cells and fixed in 70% ethanol. The fixed cells were stained with 50 µg/ml propidium iodide (Sigma- Aldrich) in PBS containing 0.5 mg/ml RNAse (Hoffmann-La Roche) and assayed as previously described (20). Cell apoptosis was analyzed by a FACS Calibur apparatus (Becton Dickinson) equipped with an argon laser tuned to 488 nm. About 10,000 cells were recorded per assay.

Statistical analyses. Data are means ± SE for the number of experiments performed in duplicate or triplicate. The significance of the differences between experimental values was assessed by the unpaired Student's t-test, and a P value <0.05 was considered to be statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Galpha olf is expressed in human normal pancreas, insulinomas, testis, and kidney epithelial cells. We tested various protocols to obtain effective transfection of the insulin-secreting beta TC-3 cell line with the expression vectors encoding AGalpha olf, AGalpha s, and ACs. Because beta TC-3 cells were hardly transfectable in both stable and transient transfection assays, pilot experiments were performed with the human embryonic kidney HEK-293T epithelial cells, which are susceptible to high expression of transgenes after transient transfection by the LipofectAMINE method. We therefore used RT-PCR to confirm the expression of the Galpha olf transcripts in human pancreas, insulinomas, and testis, and to investigate the possible expression of the Galpha olf gene in human kidney epithelial cells (Fig. 1). The predicted size of the 526-bp Galpha olf product was characterized in three human insulinomas (Fig. 1A, lanes 1-3). As expected, the Galpha olf transcripts were much more abundant in the three insulinomas, compared with their corresponding nontumorous pancreatic tissues (control tissues), because only specimen 2 was positive (Fig. 1B, lanes 1-3). Our data therefore suggest that Galpha olf can play a regulatory role during the transformation of the pancreatic beta -cells, including deregulation of insulin biosynthesis and secretion. The Galpha olf transcript was also detected in a human testis as positive control, in human embryonic kidney HEK-293T cells, and adult immortalized kidney epithelial HCD cells (Fig. 1C). To confirm the accuracy of these results, the Galpha olf PCR products were sequenced and analyzed in the GenBank database and were 100% identical to the corresponding human Galpha olf sequence. As previously shown in our laboratory, Galpha olf was specifically expressed in insulin granules of pancreatic beta -cells. To confirm this observation, we also amplified the 444-bp fragment corresponding to the human insulin transcript in all three of the above insulinomas and normal pancreatic tissues (Fig. 1B). As internal RT-PCR control, the 574-bp fragment of human GAPDH was detected in all human tissue samples.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1.   Galpha olf expression in human insulinomas, pancreas, and kidney epithelial cells. Total RNAs were extracted from 3 human insulinomas (A), their paired control pancreatic tissues (lanes 1-3; B), human testis (C), human embryonic kidney cells HEK-293T, and the SV40-immortalized human collecting duct (HCD) cell line. RT-PCR was performed as described in MATERIALS AND METHODS. In all cases, the specificity of the amplified bands was confirmed by DNA sequencing. Three independent batches of RNA gave the same results. Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is shown in bottom panel of all 3 sections, normalizing the loading samples.

Transient expression of ectopic AGalpha olf and AGalpha s enhances cAMP generation in human embryonic kidney HEK-293T cells. Because HEK-293T cells express the Galpha olf gene, we used this homologous system to study the possible effect of this G protein on the endogenous ACs (Fig. 2). We therefore generated a eukaryotic expression vector for AGalpha olf, as described in MATERIALS AND METHODS. The recombinant AGalpha olf vector was engineered so as to have an in-frame HA-epitope-tag at the NH2-terminal end of this protein. To determine the optimal level of ectopic AGalpha olf expression and function, the kinetics of its expression were monitored for 24, 48, and 72 h, using transient transfection of HEK-293T cells with 1 µg AGalpha olf plasmid (Fig. 2A). Maximal accumulation of the HA-AGalpha olf protein (46 kDa) was observed 48 h after transfection, and similar kinetics were observed for HA-AGalpha s (52 kDa), as shown in Fig. 2A. We used the same filter for beta -actin immunoblot, which acted as protein-loading control. HEK-293T cells were transfected by different amounts of expression vectors for AGalpha olf (1 µg) and AGalpha s (0.2 µg) to identify the kinetics of their maximal expression (48 h). Lower amounts of the AGalpha olf expression vector (0.1 to 0.5 µg) resulted in lower signals, using the Western blot and cAMP assays. The observed higher expression of AGalpha s vs. AGalpha olf subunit (1.7-fold at 24 and 72 h; 2.4-fold at 48 h) was likely related to the differential stability of the corresponding messengers and proteins, because the HA antibody has similar affinity for this epitope in the HA-tagged AGalpha s and AGalpha olf proteins. The aim of this study was to identify the AC isotype preferentially activated by Galpha olf. In our experiment, the AGalpha s protein also constitutes an internal control of the functional activity of a given AC isotype introduced, compared with FK.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2.   Kinetics of the transient expression of ectopic AGalpha olf and AGalpha s proteins in human embryonic HEK-293T kidney cells: Western blot analysis and cAMP production. Cultured HEK-293T cells (75 × 103 cells/dish) were transiently transfected with the pCEFL plasmid vector, alone, or recombined with the cDNA encoding the hemagglutinin (HA) epitope-tagged AGalpha olf or AGalpha s subunits, together with the pCMV-beta -gal expression vector, using the LipofectAMINE Plus reagent. A: at the times indicated, cell lysates were collected and assayed for the expression of HA-tagged AGalpha olf and AGalpha s by immunoblot. The accompanying beta -actin immunoblot of the same filter served as protein-loading control. B: in parallel experiments, total cell lysates and conditioned media underwent cAMP extraction and measurement by radioimmunoassay, as described in MATERIALS AND METHODS. cAMP generation was expressed as the percentage of control cAMP activation measured in HEK-293T cells transfected with AGalpha olf or AGalpha s, and it was compared with the cotransfections performed with the empty control vector pCEFL. Data are means ± SD of 4 independent experiments performed in duplicate and are normalized for beta -galactosidase activity and protein content.

Next, we determined the level of cAMP generation in HEK-293T cells transiently transfected with the control pCEFL vector, AGalpha olf, and AGalpha s during this period of 24, 48, and 72 h (Fig. 2B). When these cells were transfected with 1 µg AGalpha olf plasmid, the basal level of cAMP production rose in proportion to the rate of accumulation of transgene protein. At 24 h, control cAMP production was 11 ± 0.5 pmol/mg protein in HEK-293T cells transfected with pCEFL and 30 ± 1 pmol/mg protein in HEK-293T cells transfected with AGalpha olf. cAMP production induced by AGalpha olf reached its highest level 48 h after transfection. AGalpha s also enhanced cAMP production in HEK-293T cells at 24 h, and maximal stimulation of endogenous AC was observed at 48 h, constituting a 40-fold increase over the control levels measured in pCEFL-transfected cells. Therefore, AGalpha s was much more efficient than AGalpha olf in activating the endogenous AC in HEK-293T cells. On the basis of this observation, we next compared the relative ability of AGalpha olf and AGalpha s to stimulate ectopic AC isoforms in transiently transfected HEK-293T cells, after the 48-h posttransfection period was considered.

Selective activation of AC isoforms by AGalpha olf and AGalpha s. With the use of transient cotransfection assays, we compared the sensitivity of eight distinct AC isoforms to AGalpha olf and AGalpha s in HEK-293T cells (Fig. 3). First, we attempted to establish whether or not the ectopic AC isoforms introduced were functionally competent for cAMP generation in our experimental model (Fig. 3A). For this purpose, HEK-293T cells were transiently transfected by a given AC isotype (ACI-VIII) or the pCEFL control vector and challenged for 1 h by the AC activator FK. The amount of cAMP generated by a given ectopic AC isoform was reduced by its corresponding intrinsic activity measured in the absence of FK and indexed by the same cAMP values as those obtained with the endogenous AC, i.e., FK (ectopic AC) - ectopic AC, vs. the values obtained with endogenous AC: FK (pCEFL) - pCEFL. As shown in Fig. 3A, transfection of HEK-293T cells by the ACI-VII isoforms induced an increase in cAMP generation 1.5- to 3-fold greater than that measured with endogenous AC. In the case of AC-VIII, FK-stimulated cAMP levels rose 10-fold more than with endogenous AC, suggesting that this isoform is more sensitive to effective stimulation by FK. In parallel experiments, we compared the ability of AGalpha olf or AGalpha s to mimic the effect of FK on the ectopic ACI-VIII (Fig. 3A). We first observed that AGalpha olf induced 0.9- to 27-fold increases in the activity of the ectopic AC isoforms introduced by transient transfection into HEK-293T cells, the largest increases being those for AC-I and -VIII (15- and 27-fold, respectively). In comparison, AGalpha s enhanced the activity of all ectopic AC isoforms considered ~45- to 60-fold. Accordingly, AGalpha olf was ~40% as effective as AGalpha s in stimulating ectopic AC-I and -VIII; in the presence of ectopic AC-I, total cAMP levels generated were increased from 42 ± 6 to 245 ± 23 and 487 ± 63 pmol/mg protein by AGalpha olf and AGalpha s, respectively. Similarly, cAMP generation in HEK-293T cells transfected by the AC-VIII expression vector was 197 ± 15 pmol/mg protein in control cells and was further increased to 1,709 ± 380 and 4,399 ± 340 pmol/mg protein by AGalpha olf and AGalpha s, respectively.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   Differential activation of ectopic adenylyl cyclase (AC) isoforms by AGalpha olf and AGalpha s in HEK-293T cells. A: cAMP generated by the AC isoforms (0.2 µg plasmid cDNA) was measured in HEK-293T cells and expressed as the fold elevation of forskolin (FK)-induced activation by each ectopic AC minus its basal activity vs. the corresponding values obtained from endogenous AC in HEK-293T cells submitted to mock transfections by the control pCEFL vector. B: relative activation of ectopic AC isoforms I to VIII by AGalpha olf vs. AGalpha s. HEK-293T cells were transfected with 0.2 µg plasmid cDNA encoding 1 of the AC isoforms considered, alone, or combined with pCEFL-AGalpha olf or pCEFL-AGalpha s, and 0.1 µg pCMV-beta -gal plasmid for transfection efficiency normalization. Results are expressed as the percentage of ectopic AC activation by AGalpha olf, minus endogenous AC activation by AGalpha olf, over the corresponding values obtained by AGalpha s activation of ectopic and endogenous ACs. Data are means ± SD of 4 independent experiments performed in duplicate.

Next, we examined the ability of Galpha olf to activate the recently discovered rat sAC isoform reported to be insensitive to G proteins and preferentially expressed in testis, sperm, and kidney that also express Galpha olf (8). We therefore transiently transfected HEK-293T cells with the pBK-CMV vector encoding the full-length sAC isoform, either alone or combined with the AGalpha olf or AGalpha s expression plasmid. As observed for the membrane-bound AC isoforms described above, ectopic expression of the sAC isoform raised cAMP levels from 9 ± 3 in pCEFL-transfected cells to 61 ± 5 pmol/mg protein (Fig. 4). The rise in cAMP generation attributed to sAC in transfected HEK-293T cells was further enhanced by MnCl2, in agreement with the results of a previous study (8). In contrast, endogenous ACs in HEK-293T cells were insensitive to MnCl2, suggesting that these cells do not express sAC. Similarly, sAC was insensitive to AGalpha olf, but it was activated almost 2.5-fold by AGalpha s, according to the differential accumulation of cAMP measured in AGalpha s plus sAC-transfected cells vs. AGalpha s alone. In parallel experiments, AGalpha olf increased cAMP production by endogenous ACs in HEK-293T cells from the control level of 9 ± 3 measured in pCEFL-transfected cells to 31 ± 7 pmol/mg protein in AGalpha olf-transfected HEK-293T cells (Fig. 4).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Differential activation of ectopic soluble AC (sAC) by AGalpha olf and AGalpha s in HEK-293T cells. cAMP production was measured in HEK-293T cells transiently transfected with 0.2 µg of the pBK-CMV vector carrying the full-length sequence of sAC, either alone or combined with pCEFL-AGalpha olf or pCEFL-AGalpha s, and 0.1 µg pCMV-beta -gal plasmid for transfection efficiency normalization. The activity of endogenous AC and ectopic sAC in HEK-293T cells was also measured with or without 5 mM MnCl2. Results are expressed as percent of the maximal cAMP production induced by AGalpha s + sAC. Data are means ± SD of 4 independent experiments performed in duplicate.

Establishment and characterization of beta TC-3 cell lines stably transfected with wt- or constitutively activated AGalpha olf. beta TC-3 cells were stably transfected with wtGalpha olf or constitutively activated AGalpha olf using the LipofectAMINE Plus reagent. After selection by G-418, individual colonies were ring-cloned or pooled for further analysis. As shown in Fig. 5A, we isolated by immunoblot seven stable beta TC-3 clones overexpressing the wtGalpha olf protein (46-kDa band). This overexpression was confirmed by RT-PCR in clones 3, 8, 9, and 14 of beta TC-3 cells stably transfected with wtGalpha olf, which expressed the expected size of the 519-bp product corresponding to the Galpha olf transcript (Fig. 5B). We also identified, by RT-PCR, four pools of colonies that were positive for the ectopic overexpression of AGalpha olf (pools 1-4). We therefore decided to extend our studies of cAMP generation and insulin status in stably transfected beta TC-3 cells overexpressing wtGalpha olf (clones 9 and 14) or AGalpha olf (pool 2).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 5.   Ectopic overexpression of wild type (wt) and AGalpha olf by imunoblotting and RT-PCR in stably transfected beta TC-3 cells. A: beta -cells transfected with wtGalpha olf were selected by the neomycin analog G-418 (Geneticin), and resistant colonies were amplified. Equal amounts of protein (200 µg) were separated by SDS-PAGE and subjected to immunoblotting using either the polyclonal antibody K-19 directed against Galpha olf or the monoclonal antibody AC-15 specific for beta -actin as loading control. Stable overexpression of wtGalpha olf (B) and AGalpha olf (C) revealed by RT-PCR in neomycin-resistant beta TC-3 cells; the transcript of the Galpha olf transgene was clearly detected as the expected 519-bp product and was normalized by the 574-bp product of GAPDH. Data are representative of 3 experiments.

cAMP generation and insulin secretion in stably transfected beta TC-3-wtGalpha olf or -AGalpha olf cells. As shown in Fig. 6A, cAMP levels in parental beta TC-3 cells rose from the basal level of 14.3 ± 1.9 pmol/106 cells to 28.7 ± 5.2 and 41.2 ± 7.2 pmol/106 cells after the addition of the phosphodiesterase inhibitor IBMX (0.5 mM) or the insulinotropic hormone tGLP-1 (0.1 µM). Combined addition of IBMX and tGLP-1 resulted in a synergistic cAMP response consisting of a 12.5-fold increase over basal levels. Similarly, ectopic overexpression of wtGalpha olf exerted cooperative action on the cAMP generation induced by tGLP-1, alone or combined with IBMX, which was not observed when beta TC-3-AGalpha olf cells were challenged with these two effectors. In agreement with the results for cAMP, Fig. 6B shows that combined addition of IBMX and tGLP-1 enhanced insulin secretion in parental beta TC-3 cells from the basal level of 1.7 ± 0.3 to 4.4 ± 1 mU/106 cells. In contrast, the response of insulin was abolished in both beta TC-3-wtGalpha olf and -AGalpha olf cells when they were challenged with IBMX, tGLP-1, or both. Less insulin was always secreted in beta TC-3 cells expressing wtGalpha olf than in parental and beta TC-3-AGalpha olf cells. Thus long-term activation of the cAMP pathway by wt- and AGalpha olf affected the insulin secretion capacity of beta TC-3 cells in response to activation by the serpentine tGLP-1 receptor. To explore this hypothesis, we next examined the insulin status (insulin secretion and content) of parental and stably transfected beta TC-3-wtGalpha olf and -AGalpha olf cells cultured for 24 h in standard medium.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 6.   cAMP generation (A) and insulin secretion (B) in beta TC-3 cells stably transfected with wt- and AGalpha olf. Parental and transfected beta TC-3 cells were incubated for 1 h at 37°C, in the absence (Control) or presence of the phosphodiesterase inhibitor isobutylmethylxantine (IBMX; 0.2 mM), truncated glucagon-like polypeptide 1 (tGLP-1; 0.1 µM), or both. Cells then underwent RIA for cAMP or insulin. Data are means ± SD of 3 independent experiments performed in triplicate.

Insulin status and expression of the proinsulin convertases PC-1 and PC-2 in parental and stably transfected beta TC-3-wtGalpha olf and -AGalpha olf cells. The inability of beta -cells to increase insulin secretion, processing, and biosynthesis coincided with the onset of hyperglycemia. As shown in Fig. 7A, stable overexpression of wt- and AGalpha olf in beta TC-3 cells reduced constitutive insulin secretion by 50-75%, whereas their corresponding insulin content was reduced by only 25-50%. Insulin content was 13.1 ± 1.4, 19.9 ± 0.3 (P < 0.009), and 26.1 ± 2.1 mU/106 cells (P < 0.007) in wt-, AGalpha olf, and parental beta TC-3 cells, respectively. However, the overstimulation of the cAMP pathway (Fig. 6A) and the decreased insulin secretory capacity observed here in beta TC-3-wtGalpha olf and -AGalpha olf cells (Figs. 6B and 7A) were not due to any change in the expression of the proinsulin convertases PC-1 and PC-2 (Fig. 7B), which are located together with Galpha olf in the insulin secretory granules (33).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 7.   Insulin secretion, insulin content, and expression of the PC-1/ PC-2 convertases in beta TC-3 cells stably transfected by wtGalpha olf or AGalpha olf. A: insulin secretion and content (mU/106 cells) were measured in parental and beta TC-3 cells stably transfected with wtGalpha olf and AGalpha olf and cultured for 24 h. Data are means ± SD of 3 independent experiments performed in triplicate. B: Western blot analysis of the endoproteases PC-1 (66 and 87 kDa: lanes 1-3) and PC-2 (66 and 75 kDa: lanes 4-5) in beta TC-3 cells, before (parental cells: lanes 1 and 4) and after ectopic expression in these cells of wtGalpha olf (lanes 2 and 5) or AGalpha olf (lanes 3 and 6). Data were normalized by beta -actin staining (43 kDa) and are representative of 2 other experiments.

Overexpression of Galpha olf induced beta TC-3 cell survival. As hyperglycemia occurs when a relative insulin deficiency appears, beta -cell secretory dysfunction is a key element in type 2 diabetes. Up till now, insulin secretion deficiency has been attributed to pancreatic beta -cell "exhaustion" processes. Recent data suggest that apoptotic mechanisms explain insulin deficiency through a reduction in the absolute number of pancreatic beta -cells (31, 32). Although the mechanisms responsible for inducing beta -cell apoptosis are largely unknown, signaling through the G protein-coupled receptors linked to the cAMP-dependent signaling pathway has been suspected to be involved in cell survival (45). We therefore used propidium iodide staining and FACS analysis to examine the role of AGalpha olf in the survival of cultured beta -cells after serum withdrawal as an apoptotic inducer (Fig. 8). Accordingly, parental beta TC-3 and beta TC-3-AGalpha olf were deprived of serum for 24 and 48 h, and the apoptotic response was assayed. The results were compared with those for serum-treated cells. AGalpha olf promoted the survival of cultured mouse beta -cells deprived of serum for 24 h, and this protective effect was potentiated at 48 h. As demonstrated in Fig. 8, the number of cultured parental beta TC-3 cells that underwent apoptosis in the absence of serum rose significantly from 11.6% at 24 h to 18.6% at 48 h, whereas the average proportion of serum-treated cells undergoing apoptosis during this period was only 8%. In the presence and absence of serum, AGalpha olf protected beta TC-3 cells from apoptosis. Only 3% of beta TC-3-AGalpha olf cells underwent apoptosis under all conditions tested. We observed that stable overexpression of wtGalpha olf was associated with 5% of apoptotic cells in beta TC-3-wtGalpha olf cells that were serum starved for 24 h (data not shown). This finding is consistent with the observation that wtGalpha olf also induced long-term activation of the cAMP pathway, leading to alterations in the insulin secretion capacity.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of ectopic expression of AGalpha olf in beta TC-3 cells on the apoptosis induced by serum withdrawal. Parental and beta TC-3 cells stably transfected by AGalpha olf were plated in 60-mm-diameter dishes (0.75 × 106 cells), with or without serum. After 24 (left) or 48 h (right), cultured beta TC-3 cells were stained with propidium iodide, and DNA content was quantified by fluorescence-activated cell sorter analysis (see MATERIALS AND METHODS). Data are means ± SD of 3 independent experiments performed in duplicate.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The initial postulate of this study was that Galpha olf exerts preferential action on specific AC isoforms, according to its structural differences with Galpha s (23, 27). We also investigated the possible role of Galpha olf on insulin status, using the mouse secreting beta TC-3 cell line in culture, because we found that Galpha olf was present in insulin secretory granules of pancreatic beta -cells (2). Several studies by others and us (17, 21, 28) demonstrated that all of the membrane-bound ACI-VIII isoforms are present in beta -cells. In pilot experiments, we showed that the diterpene FK and constitutively activated Galpha sR201C markedly simulated the enzyme activity of the ectopic ACI-VIII isoforms when these were transiently introduced into transfected HEK-293T epithelial cells. AC activation by FK and Galpha s is initiated by dimerization of the C1 and C2 catalytic core present in these cAMP-producing enzymes (42).

In the present study, we found that Galpha olf stimulates the AC-I and -VIII isoforms preferentially. These two ACs are present in pancreatic islet beta -cells, and their levels of expression are strongly elevated in the Goto-Kakizaki (GK) rat, a widely accepted genetic rodent model of human type 2 diabetes (21). Thus Galpha olf preferentially activates two AC isoforms that are overexpressed in the beta -cells of diabetic animals. Most importantly, the Ca2+/calmodulin signaling pathways that are critical mediators of insulin granule exocytosis also regulate AC-I and -VIII isoforms. The results of previous studies suggested that the Galpha olf subunit has a functional role in AC-III isoform activation, because these two signaling proteins are coexpressed in olfactory epithelium, testis, pancreatic beta -cells, and GK rat islets (1, 4, 11, 17, 23, 46). Similarly, odorant receptors were suggested to activate AC-III via GTP-bound Galpha olf (41), and two point mutations in the promoter region of the AC-III gene have been associated with overexpression of the AC-III isoform in diabetic GK rats (1). However, we demonstrated here that Galpha olf exerts no functional interaction with the AC-III isoform in transiently transfected HEK-293T cells, indicating that such correlation may not have biological significance. The preferential action of Galpha olf in activating both AC-I and -VIII might be due to the remarkable sequence homology between these two AC isotypes in the catalytic core. In contrast, the corresponding region of AC-III exhibits divergences between two amino acids A-1014 and N-1029, which might preclude functional interactions between Galpha olf and AC-III, vs. AC-I and AC-VIII. Similarly, Galpha s and Galpha olf also exhibited two differences between amino acids S352T and R356K at interacting AC sites. In addition, upstream signals emitted by the activated serpentine receptors can also greatly affect the relative efficiencies of Galpha olf and Galpha s in interacting with and stimulating differentially the eight membrane-bound AC isoforms. These enzymes are key elements in the transmission of signals from various insulin secretagogues such as tGLP-1 and GIP, which are known to induce cAMP production, insulin biosynthesis, and secretion (13). Similar to AC-III, sAC was not affected here by Galpha olf, whereas the divalent cation Mn2+ enhanced sAC-mediated cAMP generation, as previously described (8).

In the second part of this study, we demonstrated that the overexpression and constitutive activation of Galpha olf in mouse beta TC-3 cells are associated with a decrease in insulin content and secretion. We noted with interest that wtGalpha olf consistently elevated cAMP levels in beta TC-3 cells when these cells were challenged by tGLP-1 and IBMX. This observation suggests that constitutive activation of the cAMP-generating system by Galpha olf overexpression induced the desensitization of the insulin release controlled by serpentine receptors. Similarly, we recently demonstrated that chronic stimulation of HIT-T15 beta -cells by glucose attenuates insulin release by inducing a nonfunctional state of both Galpha olf and Galpha s (35). Furthermore, defects in the autophosphorylation and catalytic activity of cytosolic nucleoside diphosphokinase, through which GDP is converted to GTP on G proteins, were found in GK rats (34). This defective conversion is also complementary to the newly discovered mechanism by which insulin regulates its own secretion. Specifically, it has been demonstrated that, after insulin receptor knockout, mice manifest severe progressive glucose intolerance due to the loss of the glucose-stimulated acute phase of insulin release, which in beta -cells is identical to Galpha olf overexpression (26). This insulin impairment in our studies is not due to the modification of insulin-processing machinery, because the expression levels of the PC-1 and PC-2 convertases remained unchanged in Galpha olf-transfected cells. cAMP is known to activate both PKA and Epacs/cAMP-GEFs in beta -cells, leading to the activation of Rap1, a small GTPase involved in cell proliferation, differentiation, and morphogenesis (12, 29). In this connection, we previously showed that Galpha olf is expressed in human pancreatic islets in 23-wk-old fetuses (15). Therefore, Galpha olf may be involved in the signals governing endocrine pancreatic development, beta -cell growth, differentiation, and survival. The coordination of these cellular activities governs the proper dynamic organization of islet morphogenesis and the functional restoration of the beta -cell mass in diabetes.

Pancreatic beta -cells are responsible for maintaining the body's nutrient levels within a very narrow range of variations, to compensate and maintain normoglycemia. During postnatal development and in adults, low levels of beta -cell replication and apoptosis are offset by a slowly increasing beta -cell mass. In type 2 diabetes, glucotoxicity and lipotoxicity due to a sedentary life and overnutrition contribute to the functional impairment of the endocrine pancreas. Recent findings suggest that cell death could explain insulin deficiency through a reduction in the absolute number of pancreatic beta -cells as a result of different insults induced by glucose, fatty acid, and nitric oxide production (31, 32). Here, we demonstrated that AGalpha olf provides remarkable protection against apoptosis in insulin-secreting beta TC-3 cells cultured with or without serum. This demonstration is supported by the results of recent studies indicating that cAMP reduces the apoptosis induced by cycloheximide in baby hamster kidney fibroblasts (45). Similarly, activated PKA was found to mediate neuronal survival through the phosphorylation and inactivation of the glycogen synthase kinase 3-beta (30).

On the basis of the present findings, molecular alterations and the deregulated overexpression of Galpha olf can be considered as mechanisms potentially involved in the beta -cell dysfunctions found in diabetic patients. In this connection, two intronic polymorphisms have been identified in the human Galpha olf gene that might cause aberrant splicing of Galpha olf mRNA (6). In conclusion, the present results demonstrated that 1) Galpha olf directly and preferentially activates AC-I and -VIII, two cAMP-generating enzymes expressed in beta -cells and deregulated in diabetic animals, and that 2) the Galpha olf subunit is involved in regulating insulin status and survival in pancreatic beta -cells.

Perspectives

Although this study focused on the AC isotypes as downstream effectors of the Galpha olf-signaling pathways, the membrane receptors inducing upstream activation of this Galpha subunit in pancreatic beta -cells are still unknown. On the basis of our data and previous studies, it became apparent that the Galpha olf-signaling pathways, including their downstream nuclear targets, might play a crucial role in pancreatic endocrine development via beta -cell differentiation and survival and the regulation of insulin secretion in diabetes. Accordingly, invalidation of the Galpha olf gene resulted in severe postnatal defects, leading to 75% mortality in the newborn mice (5). Future studies will be conducted to explore the pathophysiological impact of the activated form of the Galpha olf subunit expressed in beta -cells on the development of transgenic animals.


    ACKNOWLEDGEMENTS

We thank Dr. R. R. Reed at the Johns Hopkins University School of Medicine (Baltimore, MD) for providing the rat Galpha olf cDNA and Drs. Z. Vogel (Weizmann Institute of Science, Rehovot, Israel) and L. Levin (Weill Medical College, Cornell University, NY) for AC expression vectors. We also thank L. Cross, C. Boissard, and M. Kornprobst for technical assistance and Dr. Kitabgi for providing the pAbs directed against the PC-1 and -2.


    FOOTNOTES

This work was supported by Institut National de la Santé et de la Recherche Médicale.

Address for reprint requests and other correspondence: S. Emami, Institut National de la Santé et de la Recherche Médicale U482, Saint-Antoine Hospital, 75571 Paris Cedex 12, France (E-mail: emami{at}st-antoine.inserm.fr).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpregu.00374.2001

Received 5 July 2001; accepted in final form 15 November 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abdel-Halim, SM, Guenifi A, He B, Yang B, Mustafa M, Hojeberg B, Hillert J, Bakhiet M, and Efendic S. Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes. Diabetes 47: 498-504, 1998[Abstract].

2.   Astesano, A, Regnauld K, Ferrand N, Gingras D, Bendayan M, Rosselin G, and Emami S. Cellular and subcellular expression of Golf/Gs and Gq/G11 alpha -subunits in rat pancreatic endocrine cells. J Histochem Cytochem 47: 289-302, 1999[Abstract/Free Full Text].

3.   Avidor-Reiss, T, Nevo I, Saya D, Bayewitch M, and Vogel Z. Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272: 5040-5047, 1997[Abstract/Free Full Text].

4.   Bakalyar, HA, and Reed RR. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science 250: 1403-1406, 1990[Abstract/Free Full Text].

5.   Belluscio, L, Gold GH, Nemes A, and Axel R. Mice deficient in G(olf) are anosmic. Neuron 20: 69-81, 1998[ISI][Medline].

6.   Berrettini, WH, Vuoristo J, Ferraro TN, Buono RJ, Wildenauer D, and Ala-Kokko L. Human Golf gene polymorphisms and vulnerability to bipolar disorder. Psychiatr Genet 8: 235-238, 1998[ISI][Medline].

7.   Broer, Y, Fouchereau M, and Rosselin G. Dosages radio-immunologiques de l' AMPc et du GMPc. Préparation, purification et contrôle du 2'0 succinyl AMP-3'5'-cyclique et du 2'0 succinyl-GMP-3'5'-cyclique. C R Acad Sc (Paris) 275: 619-622, 1972.

8.   Buck, J, Sinclair ML, Schapal L, Cann MJ, and Levin LR. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc Natl Acad Sci USA 96: 79-84, 1999[Abstract/Free Full Text].

9.   Cali, JJ, Zwaagstra JC, Mons N, Cooper DM, and Krupinski J. Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 269: 12190-12195, 1994[Abstract/Free Full Text].

10.   D'Ambra, R, Surana M, Efrat S, Starr RG, and Fleischer N. Regulation of insulin secretion from beta -cell lines derived from transgenic mice insulinomas resembles that of normal beta -cells. Endocrinology 126: 2815-2822, 1990[Abstract].

11.   Defer, N, Marinx O, Poyard M, Lienard MO, Jegou B, and Hanoune J. The olfactory adenylyl cyclase type 3 is expressed in male germ cells. FEBS Lett 424: 216-220, 1998[ISI][Medline].

12.   De Rooij, J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, and Bos JL. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275: 20829-20836, 2000[Abstract/Free Full Text].

13.   Emami, S, Regnauld K, Ferrand N, Astesano A, Pessah M, Phan H, Boissard C, Garel JM, and Rosselin G. Stimulatory transducing systems in pancreatic islet cells. Ann NY Acad Sci 865: 118-131, 1998[Abstr